Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of the Detection of Circulating Tumor Cell and Circulating Tumor DNA in the Diagnosis of Metastasis in Gastric Cancer

NCT05208372 is registered in ClinicalTrials.gov with First Hospital of China Medical University as lead sponsor.

NCT NCT05208372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05208372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of the Detection of Circulating Tumor Cell and Circulating Tumor DNA in the Diagnosis of Metastasis in Gastric Cancer
Lead sponsor
First Hospital of China Medical University
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
January 31, 2024
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastasis, stomach neoplasms